Sundrug Co Ltd (JP:9989)
:9989
9989 Stock Chart & Stats
¥4137.00
¥29.00(0.71%)
At close: 4:00 PM EST
¥4137.00
¥29.00(0.71%)
Day’s Range― - ―
52-Week Range¥3,788.00 - ¥4,883.00
Previous CloseN/A
Volume615.50K
Average Volume (3M)271.71K
Market Cap
¥461.38B
Enterprise Value¥441.14B
Total Cash (Recent Filing)¥62.98B
Total Debt (Recent Filing)¥44.22B
Price to Earnings (P/E)14.1
Beta0.32
Next Earnings
May 15, 2026EPS Estimate
-135Next Dividend Ex-DateN/A
Dividend Yield3.04%
Share Statistics
EPS (TTM)76.61
Shares Outstanding119,331,184
10 Day Avg. Volume294,250
30 Day Avg. Volume271,706
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)1.83
Price to Sales (P/S)0.61
P/FCF Ratio63.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,830.00Price Target Upside16.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)297.52
Revenue Forecast (FY)¥914.84B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthSundrug's minimal leverage and high equity ratio provide durable financial resilience. Low debt reduces refinancing and interest-rate risk, supports investment or M&A optionality, and underpins credit access. A 11.4% ROE shows the equity base is being used efficiently over time.
Consistent Revenue And MarginsSustained top-line growth with healthy gross and operating margins indicates durable demand and operational efficiency across drugstore and pharmacy services. Stable margins across periods suggest a resilient business model able to absorb some cost fluctuations while funding reinvestment.
Strong Cash GenerationRobust operating cash conversion and recent large FCF growth show the company can self-fund store operations, maintenance capex and working capital. Strong cash generation reduces dependency on external financing and supports consistent capital allocation over the medium term.
Bears Say
Thin Net Profit MarginA sub-4% net margin leaves limited buffer against cost inflation, reimbursement cuts or price competition. In retail pharmacy, low absolute profitability makes results sensitive to input cost swings and regulatory pricing changes, posing a structural profitability risk over time.
Low Free Cash Flow ConversionDespite headline FCF growth, only 25% conversion of net income to FCF signals working capital needs or capital intensity. This limits truly discretionary cash for dividends, aggressive expansion, or acquisitions without either improving conversion or raising external capital.
Moderate Growth RatesTop-line and EPS growth are modest, consistent with a mature domestic retailer. Such steady but limited growth constrains long-term upside and makes competitive gains dependent on market share shifts or structural initiatives rather than rapid expansion.
Sundrug Co News
9989 FAQ
What was Sundrug Co Ltd’s price range in the past 12 months?
Sundrug Co Ltd lowest stock price was ¥3788.00 and its highest was ¥4883.00 in the past 12 months.
What is Sundrug Co Ltd’s market cap?
Sundrug Co Ltd’s market cap is ¥461.38B.
When is Sundrug Co Ltd’s upcoming earnings report date?
Sundrug Co Ltd’s upcoming earnings report date is May 15, 2026 which is in 38 days.
How were Sundrug Co Ltd’s earnings last quarter?
Sundrug Co Ltd released its earnings results on Feb 12, 2026. The company reported ¥76.61 earnings per share for the quarter, missing the consensus estimate of ¥83.198 by -¥6.588.
Is Sundrug Co Ltd overvalued?
According to Wall Street analysts Sundrug Co Ltd’s price is currently Undervalued.
Does Sundrug Co Ltd pay dividends?
Sundrug Co Ltd pays a Semiannually dividend of ¥66 which represents an annual dividend yield of 3.04%. See more information on Sundrug Co Ltd dividends here
What is Sundrug Co Ltd’s EPS estimate?
Sundrug Co Ltd’s EPS estimate is -135.
How many shares outstanding does Sundrug Co Ltd have?
Sundrug Co Ltd has 119,331,184 shares outstanding.
What happened to Sundrug Co Ltd’s price movement after its last earnings report?
Sundrug Co Ltd reported an EPS of ¥76.61 in its last earnings report, missing expectations of ¥83.198. Following the earnings report the stock price went down -1.11%.
Which hedge fund is a major shareholder of Sundrug Co Ltd?
Currently, no hedge funds are holding shares in JP:9989
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sundrug Co Ltd
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
9989 Stock 12 Month Forecast
Average Price Target
¥4,830.00
▲(16.75% Upside)
Technical Analysis
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---